Inhibrx Biosciences, Inc. Common Stock

INBXNASDAQUSD
131.07 USD
0.97 (0.74%)🟢PRE MARKET (AS OF 04:05 AM EDT)
🟢Market: OPEN
Open?$130.48
High?$130.48
Low?$130.48
Prev. Close?$131.45
Volume?51
Avg. Volume?402.1K
VWAP?$130.48
Rel. Volume?0.00x
Bid / Ask
Bid?$110.87 × 100
Ask?$150.78 × 100
Spread?$39.91
Midpoint?$130.83
Valuation & Ratios
Market Cap?1.9B
Shares Out?14.6M
Float?7.7M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?240.23
EPS?-$9.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.93Strong
Quick Ratio?3.93Strong
Cash Ratio?3.68Strong
Debt/Equity?12.58High
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A
P/B?
240.23HIGH
P/S?
1,477.02HIGH
P/FCF?
N/A
EV/EBITDA?
-14.3CHEAP
EV/Sales?
1,458.82HIGH
Returns & Efficiency
ROE?
-1,752.2%WEAK
ROA?
-95.6%WEAK
Cash Flow & Enterprise
FCF?$-129825000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Employees
110
Market Cap
1.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2024-05-28
Address
11025 N. TORREY PINES ROAD, SUITE 140
LA JOLLA, CA 92037
Phone: (858) 795-4220